The negative correlation between BMI and PTX3 levels during pregnancy and at 5-year follow-up supports recent studies demonstrating low PTX3 levels in patients with the metabolic syndrome and obesity [11, 35]. This evidence concerns the gene PTX3 and obesity disorder.